Keynote-811 Pembrolizumab Plus Trastuzumab And Chemotherapy For Her2+Metastatic Gastric Or Gastroesophageal Junction Cancer (Mg/Gejc): A Double-Blind, Randomized, Placebo-Controlled Phase 3 Study.
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要